These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30928700)

  • 1. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
    Patel JR; Didlick S; Bateman H
    Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
    Bannai H; Nemoto M; Tsujimura K; Yamanaka T; Kokado H; Kondo T; Matsumura T
    Vet Microbiol; 2018 Aug; 222():18-24. PubMed ID: 30080668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
    Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
    Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.
    Eady NA; Holmes C; Schnabel C; Babasyan S; Wagner B
    J Virol; 2024 Jun; 98(6):e0025024. PubMed ID: 38742875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune horses rapidly increase antileukoproteinase and lack type I interferon secretion during mucosal innate immune responses against equine herpesvirus type 1.
    Holmes CM; Babasyan S; Eady N; Schnabel CL; Wagner B
    Microbiol Spectr; 2024 Oct; 12(10):e0109224. PubMed ID: 39162558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.
    Soboll Hussey G; Hussey SB; Wagner B; Horohov DW; Van de Walle GR; Osterrieder N; Goehring LS; Rao S; Lunn DP
    Vet Res; 2011 Feb; 42(1):23. PubMed ID: 21314906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological correlates of vaccination and infection for equine herpesvirus 1.
    Goodman LB; Wimer C; Dubovi EJ; Gold C; Wagner B
    Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
    Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.